Epidermal growth factor receptor mutant T790M-L858R-V948R inhibitor from Calophyllum inophyllum L. leaf as potential non-small cell lung cancer drugs

• Հիմնական հեղինակներ: Precella Silvia (Հեղինակ), Jeremi Ongko (Հեղինակ), Yulanda Antonius (Հեղինակ)
• Ձևաչափ: Գիրք
• Հրապարակվել է: GarVal Editorial Ltda., 2024-09-01T00:00:00Z.
• Խորագրեր: article
• Առցանց հասանելիություն: Connect to this object online.

Context: Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer type, with 80-85% prevalence. Usually, NSCLC is treated by chemotherapy and radiotherapy in collaboration with gefitinib or other anticancer drugs. Those treatments have many adverse effects, such as shortness of breath, blee...